期刊文献+

2型糖尿病患者强化治疗前后血清骨钙素的变化 被引量:4

Changes of the serum osteocalcin levels in the patients with type 2 diabetes mellitus before and after intensive insulin treatment
在线阅读 下载PDF
导出
摘要 目的了解2型糖尿病(Type 2 diabetes T2DM)患者在严格控制血糖后血清骨钙素(Osteocalcin,OC)水平的变化及其影响因素。方法按1999年WHO诊断标准筛选T2DM患者44例,应用胰岛素泵强化治疗12~15天,同时给予调脂、降压等综合治疗。记录人体测量参数,计算体质量指数(Body mass index,BMI)、腰臀比(Waist-to-hip ratio,WHR),监测治疗前、后生化指标,以及空腹血清OC、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白介素-6(interleukin-6,IL-6)的变化。结果强化治疗后血清OC水平由(7.62±3.23)ng/L上升至(11.92±4.45)ng/L,有显著意义(P<0.01)。Pearson相关分析显示,治疗前后血清骨钙素的增值(ΔOC)与WHR(r=-0.339,P=0.024)、△空腹血糖(Fasting plasma glucose,FPG r=-0.890,P=0.000)、△餐后两小时血糖(2 hour post-meal blood glucose,2hPBG r=-0.364,P=0.015)、Δ超敏C反应蛋白(high-sensitivity C-reaction protein,hs-CRP r=-0.372,P=0.013)以及ΔIL-6(r=-0.334,P=0.027)成负相关。多元逐步回归分析显示,ΔFPG是影响ΔOC的独立相关因素。结论 T2DM患者强化治疗后血清OC水平比治疗前显著升高,且其增值与ΔFPG水平呈负相关,揭示了体内骨代谢与能量代谢之间存在密切关系。 Objective To investigate the changes of the serum osteocalcin levels in the patients with type 2 diabetes mellitus before and after intensive insulin treatment and its influencing factors. Methods By the diagnosis standards of WHO for T2DM in 1999, 44 patients were selected. Their anthropometric parameters were measured and their WHR as well as BMI were calculated. The clinical biochemical parameters, osteocalcin, tumor necrosis factor-α (TNF- α) and interleukin-6 (IL-6) were determined. The above-mentioned parameters were determined again after an intensive insulin therapy for 12 - 15 days. Results The serum osteoealcin levels were increased significantly after the treatment, from (7.62 ±3.23) ng/L to (11.92 ±4.45) ng/L, (P 〈0.01). The increment of the serum osteocalcin levels (△OC) was inversely correlated with the WHR (r = -0. 339, P=0. 024) , the △fasting plasma glucose (r= -0. 890, P = 0. 000), the △2 hour post-meal blood glucose ( r = - 0. 364, P = 0. 015 ), the △high-sensitivity C-reaction protein ( r = - 0. 372, P = 0. 013) and the △IL-6 ( r = - 0. 334, P = 0. 027). The multiple regression analysis showed that the AFPG was an independent related factor in the influence of the Aosteocalcin levels. Conclusion The serum osteocalcin levels in the T2DM patients were increased significantly after an intensive insulin treatment and the increment was inversely correlated with the FPG. It might indicate that there was a close relationship between the bone metabolism and the energy metabolism in the body.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2009年第4期237-242,共6页 Chinese Journal Of Osteoporosis And Bone Mineral Research
关键词 骨钙素 糖尿病 2型 炎症因子 osteocalcin diabetes mellitus, type 2 inflammatory factor
  • 相关文献

参考文献8

  • 1Elefteriou F,Ahn JD,Takeda S,et al.Leptin regulation of bone resorption by the sympathetic nervous system and CART[].Nature.2005
  • 2M Ferron,E Hinoi,G Karsenty,P Ducy.Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic disease in wild-type mice[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 3I Kanazawa,T Yamaguchi,M Yamamoto,M Yamauchi,S Kurioka,S Yano,T Sugimoto.Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes[].The Journal of Clinical Endocrinology.2009
  • 4M Zhou,X Ma,H Li,X Pan,J Tang,Y Gao,X Hou,H Lu,Y Bao,W Jia.Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals[].European Journal of Endocrinology.2009
  • 5Lee NK,Sowa H,Hinoi E, et al.Endocrine regulation of energy metabolism by the skeleton[].Cell.2007
  • 6Ducy P,Amling M,Takeda S,et al.Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass[].Cell.2000
  • 7Lee NK,Karsenty G.Reciprocal regulation of bone and energy metabolism[].Trends in Endocrinology and Metabolism.2008
  • 8Pittas AG,Harris SS,Eliades M,et al.Association between serum osteocalcin and markers of metabolic phenotype[].The Journal of Clinical Endocrinology.2009

同被引文献43

  • 1刘红,廖二元,伍贤平.骨钙素与代谢性骨病[J].国外医学(内分泌学分册),2004,24(4):239-240. 被引量:44
  • 2刘杰,苗懿德,高伯山,苟淑芹.老年男性2型糖尿病患者各种钙调激素与骨密度改变的关系[J].中国骨质疏松杂志,2004,10(4):456-458. 被引量:4
  • 3马艳芬,李万根,陈澍.胰岛素和胰岛素样生长因子对人成骨样细胞MG63骨钙素基因表达的影响[J].中国骨质疏松杂志,2007,13(6):398-401. 被引量:8
  • 4瞿勇,蓝青强,刘鹏.2型糖尿病导致骨质疏松症的机理研究进展[J].右江民族医学院学报,2007,29(5):832-833. 被引量:8
  • 5Ferron M, Hinoi E, Karsenty G, et ah Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wildtype rnice[J]. Proc Natl Acad Sci USA,2008,10(5) :5266-5270.
  • 6Shi Y, Yadav VK, Suda N, et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vi- vo. Proc Natl Acad Sci U S A, 2008, 105:20529-20533.
  • 7Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of en- ergy metabolism by the skeleton. Cell, 2007, 130:456-469.
  • 8Covey SD, Wideman RD, McDonald C, et al. The pancreatic beta cell is a key site for mediating the effects of leptin on glu cose homeostasis. Cell Metab, 2006, 4: 291-302.
  • 9Hinoi E, Gao N, Jung DY, et al. The sympathetic tone medi- ates leptin' s inhibition of insulin secretion by modulating os- teocalcin bioactivity. J Cell Biol, 2008, 183:1235-1242.
  • 10Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin recep- tor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest, 2007, 117:2860-2868.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部